Corpay's stock surged 6.13% during the intraday session on Friday, marking a significant upward movement.
The sharp rise appears to be driven by positive analyst actions. JP Morgan raised its price target on Corpay to $400 from $390, while Oppenheimer increased its target to $388 from $378.
These upward revisions from major financial institutions reflect growing optimism about the company's prospects and likely contributed to the bullish trading activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments